Pages: 186
Publisher: Springer Publishing
Year of Publication: 2008
Author(s) : Gassmann, Oliver, Reepmeyer, Gerrit, Zedtwitz, Maximilian von
Book Description:
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. It focuses on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. The findings are illustrated by cases from Europe, the US, and Asia. The book is based on the three most important challenges in pharmaceutical innovation: productivity dilemma, new technology trends, globalization and outsourcing. Due to the CTO-roundtable with 14 selected international experts in pharmaceutical R&D whose result is presented, the book has a strong perspective from senior management. With management concepts and tools enabling leaders in the pharmaceutical industry to cope with new challenges and trends
Ref : http://www.springer.com/us/book/9783540776352
